Millipore Selects Thermo Fisher Watson LIMS for its Bioanalytics Laboratories
News Dec 01, 2009
Thermo Fisher Scientific Inc. has announced that Millipore has implemented Watson LIMS within its Preclinical and Clinical Development Services group located in St. Charles, Mo.
The Preclinical and Clinical Development Services group will use Watson LIMS in its Regulatory Compliant Laboratory, a leading contract research organization (CRO) in the development, validation and application of ligand binding assays that enable the development of biopharmaceuticals and translational biomarker applications.
Millipore takes advantage of the enterprise connectivity inherent in Watson LIMS by also using Thermo Scientific Integration Manager to provide the connectivity necessary to enable Watson LIMS to be fully integrated with the laboratory’s instrumentation, other proprietary databases and ERP systems enterprise-wide. The inclusion of Thermo Scientific Designer further enables a more consistent and easy-to-use reporting system for the data created and stored in the Watson database.
By this three-fold installation of Thermo Scientific Watson LIMS, Integration Manager and Designer connecting laboratory instruments and the source of the data to the LIMS (which stores and manages the data), and the reporting tools (for analyzing the output of the data), Millipore has integrated its Regulatory Compliant Laboratory with the rest of the organization, enabling management to have access to critical laboratory data when they need it, and in a format that will allow for improved management decision-making.
This integration of a Thermo Scientific LIMS solution with multiple laboratory instruments and a management reporting tool is a vivid example of Thermo Scientific Connects in action.
Thermo Scientific Connects is a set of offerings that leverage the company’s breadth of solutions that includes LIMS, chromatography data system (CDS) capabilities with expertise in enterprise systems integration, all working seamlessly to improve the transfer of knowledge between laboratory-generated data and enterprise-level information systems. Connects assists organizations in integrating application-specific workflows, thereby transforming laboratory data into relevant business information and maximizing a company’s enterprise system investments to better support critical management decisions in today’s resource-constrained environment.
MIT researchers have developed a cryptographic system that could help neural networks identify promising drug candidates in massive pharmacological datasets, while keeping the data private. Secure computation done at such a massive scale could enable broad pooling of sensitive pharmacological data for predictive drug discovery.
The architecture of each person’s brain is unique, and differences may influence how quickly people can complete various cognitive tasks.o learn more, scientists are developing a new tool — computational models of the brain — to simulate how the structure of the brain may impact brain activity and, ultimately, human behavior.READ MORE
8th Edition of International Conference and Exhibition on Separation Techniques
Jul 29 - Jul 30, 2019